MYO - Myomo, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
0.7200
-0.0500 (-6.49%)
As of 12:42PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.7700
Open0.7700
Bid0.0000 x 800
Ask0.0000 x 1300
Day's Range0.7100 - 0.7600
52 Week Range0.6600 - 2.6900
Volume35,849
Avg. Volume69,669
Market Cap12.31M
Beta (3Y Monthly)1.01
PE Ratio (TTM)N/A
EPS (TTM)-0.8100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.75
Trade prices are not sourced from all markets
  • Business Wire5 days ago

    Myomo®'s International Distribution Partners Launch Patient Screening Days

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces that its international distributors in six countries are adopting the marketing model used successfully in the U.S. of introducing the MyoPro® powered orthosis to candidates through screening days. Myomo's Orthotics and Prosthetics (O&P) partners in Germany, Denmark, U.K., Italy, Chile and Australia have conducted or have planned screening days to demonstrate the MyoPro and evaluate individuals with arm paralysis for the devices.

  • If You Had Bought Myomo (NYSEMKT:MYO) Stock A Year Ago, You'd Be Sitting On A 73% Loss, Today
    Simply Wall St.last month

    If You Had Bought Myomo (NYSEMKT:MYO) Stock A Year Ago, You'd Be Sitting On A 73% Loss, Today

    Even the best investor on earth makes unsuccessful investments. But serious investors should think long and hard about...

  • Business Wirelast month

    Myomo Announces First Insurance Reimbursements in European Markets

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announced today that its Orthotics and Prosthetics (O&P) distribution partners in Germany and Denmark have successfully obtained their first reimbursement decisions by insurance payers for the MyoPro orthosis. In addition, these O&P providers, along with other certified firms in the UK and Italy, have a growing number of MyoPro units in the reimbursement process.

  • What Percentage Of Myomo, Inc. (NYSEMKT:MYO) Shares Do Insiders Own?
    Simply Wall St.last month

    What Percentage Of Myomo, Inc. (NYSEMKT:MYO) Shares Do Insiders Own?

    The big shareholder groups in Myomo, Inc. (NYSEMKT:MYO) have power over the company. Large companies usually have...

  • Business Wire2 months ago

    Myomo® Announces Participation in Beijing Trade Show

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces its participation in the China International Fair for Trade in Services, to be held in Beijing from May 28-31, 2019. Myomo will participate in this event together with Beijing Ryzur Medical Investment Co., Ltd. (Ryzur Medical), a growing medical device manufacturer based in Beijing.

  • Myomo, Inc. (MYO) Reports Q1 Loss, Lags Revenue Estimates
    Zacks2 months ago

    Myomo, Inc. (MYO) Reports Q1 Loss, Lags Revenue Estimates

    Myomo, Inc. (MYO) delivered earnings and revenue surprises of 15.00% and -3.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire2 months ago

    Myomo Reports First Quarter 2019 Results

    Reports 165% Year-over-Year Revenue Growth and Continued Expansion of Reimbursement Pipeline

  • Business Wire2 months ago

    Myomo to Report First Quarter 2019 Results on May 13, 2019

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the first quarter ended March 31, 2019 on Monday, May 13, 2019, before the US markets open. The Company will host a conference call on Monday, May 13, 2019 at 8:30 a.m. EDT featuring remarks by Paul R. Gudonis, Chairman and Chief Executive Officer, and David Henry, Chief Financial Officer.

  • Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
    Zacks3 months ago

    Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

    Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire3 months ago

    Myomo® Announces New Distribution Agreement for Australia / New Zealand

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with NeuroMuscular Orthotics Pty Ltd (NMO) with the goal of offering MyoPro across Australia and New Zealand. The company achieves this through direct clinical service provision to its own clients in Melbourne and Sydney, and through its sister clinic Interface Orthotics in Perth. In addition, NeuroMuscular Orthotics expands its reach throughout Australia and New Zealand by offering distribution, central fabrication and education to certified orthotist/prosthetists.

  • Business Wire3 months ago

    Myomo® Announces New Sales and Service Agreement for Chile

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with Tecnoplanta Orthopedic Laboratory with the goal of offering MyoPro in Chile.

  • Business Wire4 months ago

    Myomo® Announces New Sales and Service Agreement for Italy

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with Progettiamo Autonomia Robotics (PAR) with the goal of offering MyoPro in Italy. PAR is a unit of Progettiamo Autonomia, headquartered in Reggio Emilia, Italy, with 17 offices nationwide.

  • Business Wire4 months ago

    Myomo Makes NYSE American Section 610(b) Public Announcement

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2018 filed on March 12, 2019 with the Securities and Exchange Commission, the audited financial statements for the year ended December 31, 2018 included in the 10-K contained an audit opinion from its independent registered public accounting firm, which included a going concern emphasis of matter paragraph. This announcement is made pursuant to NYSE American Company Guide Section 610(b), which requires separate public announcement of the receipt of an audit opinion containing a going concern paragraph.

  • What Should Investors Know About Myomo, Inc.’s (NYSEMKT:MYO) Future?
    Simply Wall St.4 months ago

    What Should Investors Know About Myomo, Inc.’s (NYSEMKT:MYO) Future?

    The latest earnings announcement Myomo, Inc. (NYSEMKT:MYO) released in December 2018 revealed that losses became smaller relative to the prior year's level - great news for investors Below is myRead More...

  • Business Wire4 months ago

    Myomo Announces Participation at Two Upcoming Investor Conferences

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Chairman and Chief Executive Officer Paul R. Gudonis and Chief Financial Officer David Henry will be presenting, as well as meeting with investors, at two upcoming investor conferences.

  • Business Wire5 months ago

    Myomo Reports Fourth Quarter and Year End 2018 Results

    Reports Record Revenues and Reimbursement Pipeline for the Fourth Quarter and Full Year

  • ACCESSWIRE5 months ago

    Myomo, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 7, 2019 / Myomo, Inc. (NYSE MKT: MYO ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 7, 2019 at 4:30 PM Eastern Time. ...

  • Business Wire5 months ago

    Myomo to Report Fourth Quarter and Year End 2018 Results on March 7, 2019

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2018 on Thursday, March 7, 2019, after the US markets close. The Company will host a conference call on Thursday, March 7, 2019 at 4:30 p.m. EST featuring remarks by Paul R. Gudonis, Chairman and Chief Executive Officer, and David Henry, Chief Financial Officer.

  • GlobeNewswire5 months ago

    Investor Expectations to Drive Momentum within Enphase Energy, EQT, BorgWarner, Ringcentral, Chanticleer, and Myomo — Discovering Underlying Factors of Influence

    NEW YORK, Feb. 20, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Business Wire5 months ago

    Myomo, Inc. Announces Closing of Public Offering and Full Exercise of Over-Allotment Option

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today has closed its previously announced underwritten public offering of 3,950,000 shares of common stock at an offering price of $1.40 per share. In connection with the offering, the underwriter exercised in full its over-allotment option to purchase an additional 592,500 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock were offered by the Company.

  • Business Wire5 months ago

    Myomo, Inc. Prices Public Offering of Common Stock

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at an offering price of $1.40 per share. The Company expects to receive gross proceeds from the offering of approximately $5.5 million, excluding underwriting discounts and commissions and other offering-related expenses and excluding any exercise of the over-allotment option. If the underwriter exercises its over-allotment option in full, gross proceeds from the offering would be approximately $6.4 million, excluding underwriting discounts and commissions and other offering-related expenses.

  • Business Wire5 months ago

    Myomo, Inc. Announces Proposed Public Offering of Common Stock

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. Myomo expects to grant the underwriter a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any. All of the shares of common stock are being offered by the Company.

  • Business Wire5 months ago

    Myomo Announces CFO Succession

    Myomo Inc. (NYSE American MYO) (“Myomo,” or the “Company”), a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced that Ralph A. Goldwasser, its Chief Financial Officer, is retiring effective as of February 18, 2019. Mr. Goldwasser, age 71, will provide transitional services to the Company for an expected three-month term under a transition and consulting agreement. He will be succeeded by David Henry, effective February 18, 2019.

  • Business Wire6 months ago

    Myomo® to Present at Noble Capital Markets’ 15th Annual Investor Conference

    Myomo, Inc. , a wearable medical robotics company, today announced that it will be presenting at NobleCon15 - Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:30 AM EST - Studio 3.

  • Business Wire8 months ago

    Myomo Announces First Adolescent Patients to be Fitted with MyoPro

    Myomo, Inc., a wearable medical robotics company, has achieved recent momentum fitting and delivering MyoPro to adolescent users. Approved to assist young adults suffering from any disease or injury leaving them with a paralyzed or weakened arm, MyoPro is restoring motion and functionality to adolescents with conditions such as cerebral palsy, brachial plexus injury, and more. MyoPro is now being tested on Acute Flaccid Myelitis ("AFM") patients with promising results.